Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Free Cash Flow (2024 - 2025)

Historic Free Cash Flow for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$17.4 million.

  • Connect Biopharma Holdings' Free Cash Flow fell 3258.32% to -$17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.0 million, marking a year-over-year decrease of 9791.07%. This contributed to the annual value of -$24.4 million for FY2024, which is 4905.69% up from last year.
  • Per Connect Biopharma Holdings' latest filing, its Free Cash Flow stood at -$17.4 million for Q3 2025, which was down 3258.32% from -$12.9 million recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' Free Cash Flow ranged from a high of -$591000.0 in Q1 2024 and a low of -$17.4 million during Q3 2025